Thus, the inhibitory actions of Ang-(1–7) on ErbB2, as described in the present study, may be the critical step in its beneficial effects in reversing diabetes-induced vascular dysfunction; though this clearly needs further investigation. The gene discussed is ERBB2; the disease is diabetes mellitus.